Newsroom

Enveric Biosciences News

Media & Insights

Press Releases

Enveric Biosciences to Participate in the Planet MicroCap Showcase on April 21st
April 14, 2021

Enveric Biosciences Appoints Carter Ward as Chief Financial Officer
April 12, 2021

Enveric Biosciences Reports Full Year 2020 Financial Results and Provides Shareholder Update on its Accomplishments in 2021
April 01, 2021

Enveric Biosciences Appoints Dr. Douglas D. Lind to Company's Board of Directors
March 18, 2021

Enveric Biosciences to Participate in Upcoming Investor Conferences in March
March 15, 2021

Enveric Biosciences Signs Definitive Agreement to Acquire Exclusive License for Novel Molecules from Diverse Biotech
March 10, 2021

Enveric Biosciences Launches Development Collaboration and Supply Agreement with PureForm Global to Support Cannabinoid Clinical Programs
February 25, 2021

Enveric Biosciences Inc. Announces Closing of $12.8 Million Registered Direct Offering of Common Stock
February 12, 2021

Enveric Biosciences Inc. Announces $12.8 Million Registered Direct Offering
February 09, 2021

Enveric Biosciences Issues Shareholder Letter Providing Strategic Vision for Advancing Novel Prescription Supportive Care Cancer Therapies
January 19, 2021

Featured Multimedia

Featured In the News

Enveric Biosciences CEO Describes How the Group Has ‘Multiple Shots on Goal’ with Current Pipeline [Proactive Investors]

InvestorsApril 7, 2021

Featured In the News

David Johnson, Chairman and CEO of Enveric Biosciences [The Green Rush Podcast]

InvestorsMarch 25, 2021

Featured In the News

Enveric Biosciences on Acquisition of Exclusive License from Diverse Biotech and Value Catalysts [SNN]

InvestorsMarch 17, 2021

Media Coverage

Media Contact

Subscribe to Receive News Alerts

Full Name

Email *

Select your notifications *

Press Releases

SEC Filings

Stock Quotes